Top Highlights for October 2014: (Please click on read more to see details)
- India based Sun Pharma to invest more than $280 million in psoriasis drug in-licensed from Merck
- Indian Laurus Labs' minority stake acquired by Warburg Pincus, a Global private equity firm for $92 million Read more
- India’s Cipla inks pact to invest $36.65M in Iran's manufacturing unit Read more
- Trivitron Healthcare India signs 3 MoU's with Finnish firms Read more
- Cipla inks marketing pact with Teva
- Serum Institute of India to invest $160 mn to expand its operations in India
- Abbott invested $73.52 mn to set up its first greenfield manufacturing plant for nutrition in India Read more
- Indian OTC drug market to reach $6.6 billion by 2016
- India-Japan collaborate for novel medical technologies Read more
- India, Scotland join hands for research in life sciences and marine biotechnology Read more
For more such news and updates on Global Life Science Business in India please join our Group on LinkedIn by the same name.
Aagami Updates: (Please click on hyperlink to view details)
- Aagami attending BioEurope 2014 at Frankfurt, Germany Read more
- Aagami's latest Company Presentation and Case Studies are available on its company website